Johnson & Johnson MedTech performance and orthopedics spinoff review

Description Johnson & Johnson is weighing how to fix weaker MedTech performance while signaling a possible orthopedics spinoff. Overview Johnson & Johnson shares fell after its medical devices division missed expectations despite stronger pharmaceutical sales and raised full-year guidance. Management cited cardiovascular and… Read more